Related Experiment Video
Updated: Nov 24, 2025

Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts
Published on: March 2, 2017
Considerations for Implementation of a New Drug Substance Container for Subzero Storage
William J Rayfield1, William S McKechnie1, Sunitha Kandula1
1Downstream Process Development and Engineering, Biologics and Vaccines, MRL, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.
Choosing the right biologic drug substance container is crucial for global manufacturing. This study compared CryoVault™ and CelsiusPak® containers, assessing stability and leachables to ensure product quality during transport.
Area of Science:
- Biopharmaceutical Manufacturing and Supply Chain Logistics
- Container Closure Systems for Biologics
Background:
- Globalized therapeutic manufacturing requires worldwide transportation of drug substance (DS).
- This necessitates careful consideration of container selection to mitigate risks of damage, high shipment costs, and potential impact on product quality attributes, stability, and leachables.
- Existing container options for Biologics DS vary in materials and design, each presenting unique risk profiles.
Purpose of the Study:
- To evaluate a novel CryoVault™ container against a characterized CelsiusPak® bag container for Biologics DS storage.
- To assess the impact of container design and materials on product quality attributes, stability, and leachables.
- To inform the selection of an appropriate container for implementation in the drug substance manufacturing process.
Main Methods:
- Utilized a representative scale-down model to evaluate container performance.
- Conducted an extensive data package analysis, including product stability over time and temperature.
- Assessed the impact of extractables and leachables from different containers subjected to a typical freeze/thaw cycle.
Main Results:
- Comprehensive data on product stability, extractables, and leachables were generated for both container types.
- The study provided a comparative analysis of the CryoVault™ and CelsiusPak® containers under simulated transport conditions.
- Evaluation of the extensive data package facilitated a decision regarding container implementation.
Conclusions:
- The selection of an appropriate storage container is critical for maintaining Biologics DS quality during globalized manufacturing and transportation.
- Risk assessment of container design, materials, and potential leachables is essential.
- The data generated supports informed decision-making for implementing suitable container solutions in Biologics DS manufacturing processes.
Related Concept Videos
Sample Handling
Samples should be transported carefully from collection points to the laboratory. They should be properly sealed and clearly labeled to prevent cross-contamination. To preserve the sample integrity, optimal temperature conditions during transport are essential. This could involve using...
Sublimation
Drug Product Stability
Factors Influencing Drug Absorption: Pharmaceutical Parameters

